← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 1, 2008Last known activity
Apr 16, 2018
Acquired by AstraZeneca on Jan 1, 2013
Timeline
2000s
- Jan 1, 2006
Pearl Therapeutics— Founded
2010s
- Jan 1, 2013
AstraZeneca— Acquired By
Drugs by trial phase (10 distinct, 41 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Indications
Recent trials (50)
- NCT03081247Lead sponsorPhase 3Apr 16, 2018
- NCT03358147Lead sponsorPhase 2/Phase 3Dec 13, 2017
- NCT03311373Study directorPhase 1Oct 17, 2017
- NCT03311373Lead sponsorPhase 1Oct 17, 2017
- NCT03250182Lead sponsorPhase 1Aug 11, 2017
- NCT03250182Study directorPhase 1Aug 11, 2017
- NCT03075267Study directorPhase 1Mar 1, 2017
- NCT03075267Lead sponsorPhase 1Mar 1, 2017
- NCT02685293Study chairPhase 3Dec 9, 2016
- NCT02685293Lead sponsorPhase 3Dec 9, 2016
- NCT02937584Lead sponsorPhase 3Nov 1, 2016
- NCT02937584Study directorPhase 3Nov 1, 2016
- NCT03262012Study directorPhase 3Aug 9, 2016
- NCT03262012Lead sponsorPhase 3Aug 9, 2016
- NCT02766608Lead sponsorPhase 3May 31, 2016
Details
- Founded
- Redwood City, CA, US Jan 1, 2006
- Last known activity
- Apr 16, 2018